Related references
Note: Only part of the references are listed.High-Throughput Monitoring of Human Papillomavirus Type Distribution
Anna Soderlund-Strand et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study
Francesca Carozzi et al.
EUROPEAN JOURNAL OF CANCER (2012)
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
A. Szarewski et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
Peng Guan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions
Isabelle Soerjomataram et al.
LANCET (2012)
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
Catherine de Martel et al.
LANCET ONCOLOGY (2012)
Inference of Type-Specific HPV Transmissibility, Progression and Clearance Rates: A Mathematical Modelling Approach
Helen C. Johnson et al.
PLOS ONE (2012)
Modeling the Dynamic Relationship Between HIV and the Risk of Drug-Resistant Tuberculosis
Rinat Sergeev et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: A dynamic individual-based approach
Tazio Vanni et al.
VACCINE (2012)
Global Burden of Human Papillomavirus and Related Diseases
David Forman et al.
VACCINE (2012)
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age
X. Castellsague et al.
BRITISH JOURNAL OF CANCER (2011)
Genital Transmission of Human Papillomavirus in Recently Formed Heterosexual Couples
Ann N. Burchell et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Clustering of Multiple Human Papillomavirus Infections in Women From a Population-Based Study in Guanacaste, Costa Rica
Salvatore Vaccarella et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Modelling patterns of clearance of HPV-16 infection and vaccination efficacy
Iacopo Baussano et al.
VACCINE (2011)
Model-Based Estimation of Viral Transmissibility and Infection-Induced Resistance From the Age-Dependent Prevalence of Infection for 14 High-Risk Types of Human Papillomavirus
Johannes A. Bogaards et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Concurrent Infection with Multiple Human Papillomavirus Types: Pooled Analysis of the IARC HPV Prevalence Surveys
Salvatore Vaccarella et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Human Papillomavirus Infections Among Couples in New Sexual Relationships
Ann N. Burchell et al.
EPIDEMIOLOGY (2010)
Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology
Delphine Maucort-Boulch et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark
Jens Olsen et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2010)
Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
Mahboobeh Safaeian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2010)
Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis
Nicolas Van de Velde et al.
VACCINE (2010)
Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom
Yoon Hong Choi et al.
VACCINE (2010)
HPV-16 infection and cervical cancer: Modeling the influence of duration of infection and precancerous lesions
Iacopo Baussano et al.
EPIDEMICS (2010)
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16-26 Years
Cosette M. Wheeler et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J. Paovonen et al.
LANCET (2009)
Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria
Ingrid Zechmeister et al.
VACCINE (2009)
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections
Ana Cecilia Rodriguez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Sampling and sensitivity analyses tools (SaSAT) for computational modelling
Alexander Hoare et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2008)
Seroepidemiology as basis for design of a human papillomavirus vaccination program
J. Ryding et al.
VACCINE (2008)
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
Sue J. Goldie et al.
VACCINE (2008)
Multiparameter calibration of a natural history model of cervical cancer
Jane J. Kim et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion
Martyn Plummer et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Cost-effectiveness analyses of human papillomavirus vaccination
Anthony T. Newall et al.
LANCET INFECTIOUS DISEASES (2007)
Model for assessing human papillomavirus vaccination strategies
Elamin H. Elbasha et al.
EMERGING INFECTIOUS DISEASES (2007)
Modeling human papillomavirus vaccine effectiveness: Quantifying the impact of parameter uncertainty
Nicolas Van de Velde et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Third Italian national survey on knowledge, attitudes, and sexual behaviour in relation to HIV/AIDS risk and the role of health education campaigns
Carlo Signorelli et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2006)
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: Mathematical modelling analyses
Ruanne V. Barnabas et al.
PLOS MEDICINE (2006)
Role of herd immunity in determining the effect of vaccines against sexually transmitted disease
GP Garnett
JOURNAL OF INFECTIOUS DISEASES (2005)
Evaluating human papillomavirus vaccination programs
AV Taira et al.
EMERGING INFECTIOUS DISEASES (2004)
The theoretical population-level impact of a prophylactic human papilloma virus vaccine
JP Hughes et al.
EPIDEMIOLOGY (2002)
The geographical and temporal evolution of sexually transmitted disease epidemics
GP Garnett
SEXUALLY TRANSMITTED INFECTIONS (2002)
Share Paper
